I am an Associate Professor in the Department of Biology and a researcher in the Targeted Antitumor Therapies group. I am a member of the Consolidated Research Group "Cancer, Inflammation, Microbiome and Therapies" (CIMiT) (2021SGR00621), which has been recognized by the Generalitat de Catalunya.Doctor of Pharmacy, University of Barcelona (2003). I conducted a predoctoral research fellowship at Harvard Medical School in the United States (2001) and a four-year postdoctoral research fellowship at the Hepatology Unit of the Hospital Clinic in Barcelona (2003-2007). My research has been conducted in different areas of biomedicine. (1) Investigation into the role of adhesion molecules in inflammatory processes, (2) Analysis of the genetic variability of the hepatitis C virus in relation to treatment outcomes, and (3) Development of novel strategies for targeted cancer therapy. This latest line of research began with my arrival at the University of Girona in 2007. It is focused on the development of new chemotherapy and phototherapy strategies, as well as on the targeted delivery of drugs to tumors by means of carrier proteins and nanoparticles. The ultimate objective is to develop more efficacious cancer treatments with reduced adverse effects. During this period, I heve conducted interdisciplinary research in collaboration with research groups from different national and international universities.In total, I have participated in 10 funded research projects and 3 collaboration agreements with biotechnology companies. I have published over 40 articles in international journals and have supervised 4 doctoral theses.